BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 32886566)

  • 21. Vital signs: evaluation of hepatitis C virus infection testing and reporting - eight U.S. sites, 2005-2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 May; 62(18):357-61. PubMed ID: 23657111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis C virus infection among people who inject drugs in Bangkok, Thailand, 2005-2010.
    Martin M; Vanichseni S; Leelawiwat W; Anekvorapong R; Raengsakulrach B; Cherdtrakulkiat T; Sangkum U; Mock PA; Leethochawalit M; Chiamwongpaet S; McNicholl JM; Kittimunkong S; Curlin ME; Choopanya K;
    WHO South East Asia J Public Health; 2019 Apr; 8(1):50-55. PubMed ID: 30950431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors for hepatitis C seropositivity among young people who inject drugs in New York City: Implications for prevention.
    Eckhardt B; Winkelstein ER; Shu MA; Carden MR; McKnight C; Des Jarlais DC; Glesby MJ; Marks K; Edlin BR
    PLoS One; 2017; 12(5):e0177341. PubMed ID: 28542351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns of hepatitis C virus RNA levels during acute infection: the InC3 study.
    Hajarizadeh B; Grady B; Page K; Kim AY; McGovern BH; Cox AL; Rice TM; Sacks-Davis R; Bruneau J; Morris M; Amin J; Schinkel J; Applegate T; Maher L; Hellard M; Lloyd AR; Prins M; Dore GJ; Grebely J;
    PLoS One; 2015; 10(4):e0122232. PubMed ID: 25837807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improving Screening Methods for Hepatitis C Among People Who Inject Drugs: Findings from the HepTLC Initiative, 2012-2014.
    Blackburn NA; Patel RC; Zibbell JE
    Public Health Rep; 2016; 131 Suppl 2(Suppl 2):91-7. PubMed ID: 27168667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of hepatitis C and coinfection with HIV among United States veterans in the New York City metropolitan area.
    Bräu N; Bini EJ; Shahidi A; Aytaman A; Xiao P; Stancic S; Eng R; Brown ST; Paronetto F
    Am J Gastroenterol; 2002 Aug; 97(8):2071-8. PubMed ID: 12190179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crowdsourcing to promote hepatitis C testing and linkage-to-care in China: a randomized controlled trial protocol.
    Wong WCW; Yang NS; Li J; Li H; Wan EYF; Fitzpatrick T; Xiong Y; Seto WK; Chan P; Liu R; Tang W; Tucker JD
    BMC Public Health; 2020 Jul; 20(1):1048. PubMed ID: 32615951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the Impact of Mandating Health Care Providers to Offer Hepatitis C Virus Screening to All Persons Born During 1945-1965 - New York, 2014.
    Flanigan CA; Leung SJ; Rowe KA; Levey WK; King A; Sommer JN; Morne JE; Zucker HA
    MMWR Morb Mortal Wkly Rep; 2017 Sep; 66(38):1023-1026. PubMed ID: 28957037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Undiagnosed HIV and HCV Infection in a New York City Emergency Department, 2015.
    Torian LV; Felsen UR; Xia Q; Laraque F; Rude EJ; Rose H; Cole A; Bocour A; Williams GJ; Bridgforth RF; Forgione LA; Doo H; Braunstein SL; Daskalakis DC; Zingman BS
    Am J Public Health; 2018 May; 108(5):652-658. PubMed ID: 29565667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of hepatitis C infection in New York City, 2004.
    Bornschlegel K; Berger M; Garg RK; Punsalang A; McKinney CM; Gwynn RC; Thorpe LE
    J Urban Health; 2009 Nov; 86(6):909-17. PubMed ID: 19672718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Point-of-care testing for HCV infection: recent advances and implications for alternative screening.
    Parisi MR; Soldini L; Vidoni G; Mabellini C; Belloni T; Brignolo L; Negri S; Schlusnus K; Dorigatti F; Lazzarin A
    New Microbiol; 2014 Oct; 37(4):449-57. PubMed ID: 25387283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C virus prevalence and estimated incidence among new injectors during the opioid epidemic in New York City, 2000-2017: Protective effects of non-injecting drug use.
    Des Jarlais DC; Arasteh K; Feelemyer J; McKnight C; Barnes DM; Perlman DC; Uuskula A; Cooper HLF; Tross S
    Drug Alcohol Depend; 2018 Nov; 192():74-79. PubMed ID: 30243142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Wellness Coaching for People With Prediabetes: A Randomized Encouragement Trial to Evaluate Outreach Methods at Kaiser Permanente, Northern California, 2013.
    Xiao H; Adams SR; Goler N; Sanna RS; Boccio M; Bellamy DJ; Brown SD; Neugebauer RS; Ferrara A; Schmittdiel JA
    Prev Chronic Dis; 2015 Nov; 12():E207. PubMed ID: 26605707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of a Transitional Patient Navigation Protocol for People Living With Hepatitis C Virus in the New York City Jail System.
    Wiersema J; Schwartz J; Bocour A; Julian E; Chan J
    J Health Care Poor Underserved; 2024; 35(2):516-531. PubMed ID: 38828579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of Recurrent Hepatitis C Viremia Using Surveillance Data, New York City.
    Guerra K; Bocour A; Moore MS; Winters A
    J Public Health Manag Pract; 2022 Mar-Apr 01; 28(2):126-129. PubMed ID: 32956285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized trial to evaluate the use of text messaging, letter, and telephone call reminders to improve return of blood donors with reactive serologic tests.
    Porto-Ferreira FA; de Almeida-Neto C; Murphy EL; Montebello SC; Nogueira FA; Koga da Silva EM; MacFarland W; Custer B
    Transfusion; 2017 Jan; 57(1):102-107. PubMed ID: 27774609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis C Virus Incidence in a Cohort in Medication-Assisted Treatment for Opioid Use Disorder in New York City.
    Jordan AE; Cleland CM; Wyka K; Schackman BR; Perlman DC; Nash D
    J Infect Dis; 2020 Sep; 222(Suppl 5):S322-S334. PubMed ID: 32877567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Duplicate hepatitis C antibody testing in New York City, 2006-2010.
    Tsai V; Bornschlegel K; McGibbon E; Arpadi S
    Public Health Rep; 2014; 129(6):491-5. PubMed ID: 25364050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis C point-of-care diagnostics: in search of a single visit diagnosis.
    Grebely J; Applegate TL; Cunningham P; Feld JJ
    Expert Rev Mol Diagn; 2017 Dec; 17(12):1109-1115. PubMed ID: 29088981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surveillance for chronic hepatitis B virus infection - New York City, June 2008-November 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Jan; 61(1):6-9. PubMed ID: 22237029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.